Human-induced pluripotent stem cells (iPSCs) can be utilized to study complex health conditions in in vitro platforms relevant to humans. It is possible to reprogram human iPSC lines from patient ...

Life sciences researchers need a host of tools to develop and test critical disease-treating drugs and therapies, from basic research to final product release. Primary cells, media, and reagents are ...

Most potential oncology drugs fail during the drug development pipeline, even when there has been promising data for their efficacy during the in vitro stage. This makes it vital to identify in vitro ...